Medi Assist Q1 FY27 Revenue Surges 24.1% to ₹236.5 Cr; AI and International Growth On Track
Medi Assist reported Q1 FY27 operating revenue of ₹236.5 crore, a 24.1% YoY increase. EBITDA was ₹48.0 crore, and PAT was ₹27.6 crore. Technology revenue grew 55.5% to ₹7.8 crore. The company has signed seven AI platform contracts and launched operations in Thailand. Dr. Vikram Jit Singh Chhatwal transitioned to Non-Executive Chairman.
The announcement details significant revenue growth, strategic advancements in technology and international expansion, and key management changes, all of which are material to investors.
The company reported strong year-on-year revenue growth, increased profitability, and positive developments in its technology and international business segments.
Medi Assist Healthcare Services Limited announced its financial results for the first quarter of FY27, reporting a significant 24.1% year-on-year increase in operating revenue to ₹236.5 crore.
The company's EBITDA stood at ₹48.0 crore with a margin of 20.3%, while the reported Profit After Tax (PAT) was ₹27.6 crore, marking a 21.9% rise from the previous year. Adjusted PAT saw an 8.2% increase to ₹24.5 crore.
The India TPA franchise demonstrated robust growth, with group revenue reaching ₹166.0 crore (+25.5% YoY) and PUM at ₹8,454 crore (+29.5% YoY), contributing to a group market share of 37.6%.
Medi Assist has completed its planned ₹24.5 crore investment in its AI platform over the last six quarters, which is now moving from investment to early monetization with seven contracts signed. The technology revenue grew by 55.5% YoY to ₹7.8 crore.
Internationally, the company has increased its ownership in Mayfair We Care to 91.75%, establishing it as a structured international vehicle. The first technology deployment contract in Thailand went live on July 1, 2026, with multiple corporates onboarded.
The company maintains a debt-free balance sheet with a free cash position of ₹245.5 crore. Management expects technology licensing and international business to deliver meaningful EBITDA margin accretion over time, funded from operating cash flows.
In terms of governance, Dr. Vikram Jit Singh Chhatwal transitioned from Executive Chairman to Non-Executive, Non-Independent Director and Chairman, effective August 8, 2026. Mr. Gaurav Bhatnagar also joined as Chief TPA Officer and was designated as an SMP.
What to do with a filing like this
Medi Assist Healthcare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medi Assist Healthcare Services Limited. Read the original for the full detail.